Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01535742 · ClinicalTrials.gov registry record · NA
Ambu Aura-i and Air-Q Intubating Laryngeal Airways as a Conduit for Tracheal Intubation in Children
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01535742 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 120 participants.
The verdict
NCT01535742, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a clinically relevant difference in time to tracheal intubation when using fiberoptic bronchoscope as a guide to intubate through the Ambu Aura-i or air-Q ILA.
Interventions
- DEVICE Ambu Aura-i size 1.5
- DEVICE air-Q ILA size 1.5
- DEVICE Ambu Aura-i size 2
- DEVICE air-Q ILA size 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01535742
The ClinicalTrials.gov registry entry for NCT01535742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ambu Aura-i size 1.5 is the first listed.
NCT01535742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01535742 about?
NCT01535742 is a clinical study titled "Ambu Aura-i and Air-Q Intubating Laryngeal Airways as a Conduit for Tracheal Intubation in Children". The purpose of this study is to determine whether there is a clinically relevant difference in time to tracheal intubation when using fiberoptic bronchoscope as a guide to intubate through the Ambu Aura-i or air-Q ILA.
What is the current status of trial NCT01535742?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01535742?
The interventions under investigation include: Ambu Aura-i size 1.5 (DEVICE), air-Q ILA size 1.5 (DEVICE), Ambu Aura-i size 2 (DEVICE), air-Q ILA size 2 (DEVICE).
Who is sponsoring clinical trial NCT01535742?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.